| Description | LASSBio-1632 is a novel anti-asthmatic lead candidate that selectively inhibits PDE4A and PDE4D isoenzymes, leading to the suppression of airway hyper-reactivity (AHR) and TNF-α production in lung tissue. With high experimental BBB permeability, LASSBio-1632 (7j) efficiently crosses the blood-brain barrier through passive diffusion [1]. |
| molecular weight | 392.43 |
| Molecular formula | C18H20N2O6S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |